Screener Summaries Updates Institutions Sign In More Updates › Other Events › NRSN Other Events · Jun 9, 2026
On June 9, 2026, NeuroSense Therapeutics Ltd. announced it received a Japanese patent grant for its PrimeC novel… NRSN NeuroSense Therapeutics Ltd.
On June 9, 2026, NeuroSense Therapeutics Ltd. announced it received a Japanese patent grant for its PrimeC novel composition. The company operates in the biotechnology industry and develops therapeutics for neurological disorders.
More from NeuroSense Therapeutics Ltd. All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
